PINRID- pyrantel pamoate tablet 
YYBA CORP

----------

PINRID

Drug Facts

Active Ingredient (in each chewable tablet)

Pyrantel pamoate 720.5 mg

(equivalent to 250 mg pyrantel base)

Purpose

Anthelmintic

Use

for the treatment of pinworm infection

Warnings

Keep out of reach of children. Do not exceed recommended dosage.

If any of these conditions persist, consult a doctor

• dizziness
• diarhea
• abdominal cramps
• vomiting
• nausea
• headache

In case of overdose, get medical help or contact a poison control center rightaway.

If pregnant, breast-feeding, or if you have liver disease, ask a doctor before use. Contact your doctorif an allergic reaction occurs.

Directions

25-37 lb½ tablet
38-62 lbs1 tablets
63-87 lbs1½ tablets
88-112 lbs2 tablets
113-137 lbs2½ tablets
138-162 lbs3 tablets
163-187 lbs3½ tablets
over 188 lbs4 tablets

Other information:

Intactive ingredients

bubble gum flavor, citric acid, D&C red#27, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid, sucralose.

Questions or comments:

call toll free 1-866-933-6337

PRINCIPAL DISPLAY PANEL

label-24

PRINCIPAL DISPLAY PANEL

label

PINRID 
pyrantel pamoate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73581-111
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PYRANTEL PAMOATE (UNII: 81BK194Z5M) (PYRANTEL - UNII:4QIH0N49E7) PYRANTEL250 mg
Inactive Ingredients
Ingredient NameStrength
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
Product Characteristics
ColorpinkScore2 pieces
ShapeROUNDSize16mm
FlavorImprint Code PR1
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:73581-111-1212 in 1 BOTTLE; Type 0: Not a Combination Product08/01/2024
2NDC:73581-111-2424 in 1 BOTTLE; Type 0: Not a Combination Product08/01/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02408/01/2024
Labeler - YYBA CORP (006339772)

Revised: 8/2024
Document Id: 1f3a5df9-ecfd-b5f6-e063-6394a90a45b6
Set id: fc225b5b-0ce8-4394-a643-39dbc674d7cd
Version: 1
Effective Time: 20240801
 
YYBA CORP